Reciprocal Regulation of c-Src and STAT3 in Non-Small Cell Lung Cancer

Lauren A. Byers(The University of Texas MD Anderson Cancer Center), Faye M. Johnson(The University of Texas MD Anderson Cancer Center)
Clinical Cancer Research
October 28, 2009
10.1158/1078-0432.ccr-09-0767
Cited by 118

Related Papers

Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
|Cancer Cell|2021|930
Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade
|Cancer Cell|2024|154
Sustained Src Inhibition Results in Signal Transducer and Activator of Transcription 3 (STAT3) Activation and Cancer Cell Survival via Altered Janus-Activated Kinase–STAT3 Binding
|Cancer Research|2009|131
Protein expression of TTF1 and cMYC define distinct molecular subgroups of small cell lung cancer with unique vulnerabilities to aurora kinase inhibition, DLL3 targeting, and other targeted therapies
|Oncotarget|2017|92
Genomic characterization of human papillomavirus-positive and -negative human squamous cell cancer cell lines
|Oncotarget|2017|70